日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Decoding the Functional Interactome of Non-Model Organisms with PHILHARMONIC

利用 PHILHARMONIC 解码非模式生物的功能性互作组

Sledzieski, Samuel; Versavel, Charlotte; Singh, Rohit; Ocitti, Faith; Devkota, Kapil; Kumar, Lokender; Shpilker, Polina; Roger, Liza; Yang, Jinkyu; Lewinski, Nastassja; Putnam, Hollie; Klein-Seetharaman, Judith; Berger, Bonnie; Cowen, Lenore

The Reversed Halo Sign in Pulmonary Infarction due to Acute Pulmonary Embolism

急性肺栓塞引起的肺梗死中的反晕征

Schueremans, Thalinne; Versavel, Margot; Dubbeldam, Adriana

A Phase 2 Proof-of-Concept, Randomized, Placebo-Controlled Trial of CX-8998 in Essential Tremor

CX-8998治疗特发性震颤的II期概念验证性随机安慰剂对照试验

Papapetropoulos, Spyros; Lee, Margaret S; Versavel, Stacey; Newbold, Evan; Jinnah, Hyder A; Pahwa, Rajesh; Lyons, Kelly E; Elble, Rodger; Ondo, William; Zesiewicz, Theresa; Hedera, Peter; Handforth, Adrian; Elder, Jenna; Versavel, Mark

Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer's Disease

ALZ-801(一种用于治疗阿尔茨海默病的在研曲米普罗沙特前药)的临床药代动力学和安全性研究

Hey, John A; Yu, Jeremy Y; Versavel, Mark; Abushakra, Susan; Kocis, Petr; Power, Aidan; Kaplan, Paul L; Amedio, John; Tolar, Martin

Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations

慢性疼痛治疗临床试验中的患者表型分析:IMMPACT 建议

Edwards, Robert R; Dworkin, Robert H; Turk, Dennis C; Angst, Martin S; Dionne, Raymond; Freeman, Roy; Hansson, Per; Haroutounian, Simon; Arendt-Nielsen, Lars; Attal, Nadine; Baron, Ralf; Brell, Joanna; Bujanover, Shay; Burke, Laurie B; Carr, Daniel; Chappell, Amy S; Cowan, Penney; Etropolski, Mila; Fillingim, Roger B; Gewandter, Jennifer S; Katz, Nathaniel P; Kopecky, Ernest A; Markman, John D; Nomikos, George; Porter, Linda; Rappaport, Bob A; Rice, Andrew S C; Scavone, Joseph M; Scholz, Joachim; Simon, Lee S; Smith, Shannon M; Tobias, Jeffrey; Tockarshewsky, Tina; Veasley, Christine; Versavel, Mark; Wasan, Ajay D; Wen, Warren; Yarnitsky, David

Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP-432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal Subjects

在健康正常受试者中,对三重再摄取抑制剂SEP-432与双重再摄取抑制剂度洛西汀进行探索性生物标志物研究

Sramek, John J; Hardy, Larry W; Bieck, Peter; Zamora, Cynthia; Versavel, Mark; Kharidia, Jahnavi; Grinnell, Todd; Chen, Yu-Luan; Sullivan, Michael; Ding, Hong; Cutler, Neal R

Hematopoietic overexpression of FOG1 does not affect B-cells but reduces the number of circulating eosinophils

FOG1 的造血过度表达不会影响 B 细胞,但会减少循环嗜酸性粒细胞的数量

Camille Du Roure, Aude Versavel, Thierry Doll, Chun Cao, Vincent Pillonel, Gabriele Matthias, Markus Kaller, Jean-François Spetz, Patrick Kopp, Hubertus Kohler, Matthias Müller, Patrick Matthias

Inclusion and exclusion criteria for epilepsy clinical trials-recommendations from the April 30, 2011 NINDS workshop

癫痫临床试验的纳入和排除标准——2011年4月30日NINDS研讨会的建议

Fertig, Evan; Fureman, Brandy E; Bergey, Gregory K; Brodie, Mary Ann; Hesdorffer, Dale C; Hirtz, Deborah; Kossoff, Eric H; LaFrance, W Curt Jr; Versavel, Mark; French, Jacqueline

Polygenic control of an all-or-none morphological trait in Euplotes (Ciliata, Hypotrichea). Evolutionary significance of naturally occurring morphological variation in Ciliates

Euplotes(纤毛虫纲,下毛纲)中全或无形态性状的多基因控制。纤毛虫自然形态变异的进化意义

Lints, F; Gruwez, G; Génermont, J; Demar, C; Fryd-Versavel, G; Tuffrau, H; Tuffrau, M